𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.

✍ Scribed by Averbuch-Heller, L; Tusa, RJ; Fuhry, L; Rottach, KG; Ganser, GL; Heide, W; Buttner, U; Leigh, RJ

Book ID
125822770
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
349 KB
Volume
124
Category
Article
ISSN
0002-9394

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A double-blind controlled study of gabap
A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus
✍ L. Averbuch-Heller; R. J. Tusa; L. Fuhry; K. G. Rottach; G. L. Ganser; W. Heide; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 782 KB

## Abstract We conducted a double‐blind crossover trial comparing gabapentin (up to 900 mg/day) to baclofen (up to 30 mg/day) as therapy for acquired nystagmus in 21 patients. We measured visual acuity and the nystagmus before, and at the end of, 2 weeks on each medication. For a group of 15 patien

Gabapentin in the treatment of fibromyal
Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial
✍ Lesley M. Arnold; Don L. Goldenberg; Sharon B. Stanford; Justine K. Lalonde; H. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 168 KB πŸ‘ 3 views

## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin